QBE – UBS rates the stock as Buy
Buy with a target of $10.25.
Read MoreBroker News
COF – Credit Suisse rates the stock as Downgrade to Neutral
Rating is downgraded to Neutral from Outperform and the target is raised to $2.20 from $2.14.
Read MoreAST – Morgans rates the stock as Hold
The Hold rating is unchanged and the target price is decreased to $1.82 from $1.86.
Read MoreIFL – Credit Suisse rates the stock as Outperform
Credit Suisse assesses there is significant demand for advice and a large opportunity for a firm such as IOOF Holdings. Outperform reiterated. Target is $5.
Read MorePAN – Morgans rates the stock as Downgrade to Hold
Morgans downgrades to Hold from Add. However, the target price is increased to $0.18 from $0.16, partly due to positive metal prices.
Read MoreFMG – UBS rates the stock as Neutral
Neutral with a target of $18.
Read MoreANP – Morgans rates the stock as Add
The Speculative Buy and $0.38 target price are maintained.
Read MoreS32 – UBS rates the stock as Buy
The broker thinks the risk-reward on South32 is attractive and retains its Buy rating with a target of $3.30.
Read MoreAVG – Morgans rates the stock as Add
The Add rating and $0.83 target are maintained.
Read MoreIGO – Credit Suisse rates the stock as Neutral
Neutral maintained. Target rises to $6.90 from $6.40.
Read MoreSGR – Credit Suisse rates the stock as Neutral
Neutral retained. Target is raised to $4.00 from $3.85.
Read MoreUNI – Morgans rates the stock as Add
The Add rating and $8.37 target are retained while upside risk remains if the current sales trajectory continues over 4Q21.
Read MoreTAH – Morgans rates the stock as Hold
The target rises to $5.11 from $4.04 and the rating of Hold is unchanged.
Read MoreIGO – Macquarie rates the stock as Outperform
Macquarie resumes coverage with an Outperform rating and $8 target.
Read MoreBKL – Credit Suisse rates the stock as Neutral
Gross margin expansion is anticipated moving to the high 50% levels from 52%. Credit Suisse downgrades estimates for earnings per share by -2-4% and retains a Neutral rating.
Read MoreOSH – UBS rates the stock as Upgrade to Buy
UBS upgrades to Buy from Neutral, assessing the outlook for oil demand is improving and Oil Search has the highest leverage to a forecast oil price recovery. Target is reduced to $4.50 from $4.60.
Read MoreELD – Citi rates the stock as Buy
Buy rating retained with a target of $13.20.
Read MoreILU – Credit Suisse rates the stock as Underperform
Underperform rating maintained as Credit Suisse asserts there are plenty of unknowns around growth options. Target is $5.70.
Read MoreYFZ – Morgans rates the stock as Add
The target is lowered to $1.13 from $1.59.
Read MoreCTD – UBS rates the stock as Buy
Buy rating retained. Target rises to $22.00 from $21.10.
Read MoreDRR – Credit Suisse rates the stock as Outperform
The broker assesses the dislocation is a re-rating opportunity and retains an Outperform rating. Target is $4.80.
Read MoreBHP – Morgans rates the stock as Hold
While maintaining a Hold rating the analyst lifts the target price to $43.60 from $42.20, reflecting guidance changes, and upgraded iron ore/copper/thermal coal forecasts and lower met coal.
Read MoreA2M – UBS rates the stock as Buy
UBS pins its Buy rating on a meaningful recovery in indirect infant formula sales over the next two years. Target is steady at NZ$16.00.
Read MoreALX – Morgans rates the stock as Add
The target price increases to $6.31 from $6.14, due largely to forecast changes and a spot FX rate update. The Add rating is maintained.
Read MoreCGF – Credit Suisse rates the stock as Downgrade to Neutral
Credit Suisse downgrades to Neutral from Outperform, assessing the recovery story is delayed. Target is reduced to $6.05 from $6.65.
Read MoreGOR – Macquarie rates the stock as Outperform
Guidance is unchanged. Outperform rating maintained. Target rises to $1.50 from $1.40.
Read MoreWES – Credit Suisse rates the stock as Neutral
The broker retains a Neutral rating and raises the target of $57.32 from $57.04.
Read MoreAPT – Morgans rates the stock as Hold
The price target falls to $121 from $125.3, while the Hold recommendation is unchanged on valuation grounds.
Read MoreAPT – UBS rates the stock as Sell
Sell rating with a $36 price target.
Read MoreHUB – Credit Suisse rates the stock as Outperform
Credit Suisse reiterates an Outperform rating and $27.70 target.
Read MoreSYD – Morgans rates the stock as Add
Morgans lifts the target to $7.03 from $6.86 on rising passenger numbers in March. The Add rating is maintained.
Read MoreGPT – UBS rates the stock as Neutral
Neutral rating with the target rising to $4.80 from $4.55.
Read MoreSYD – Credit Suisse rates the stock as Underperform
Underperform retained. Target is raised to $5.30 from $5.00.
Read MoreORG – Morgans rates the stock as Add
The Add rating is unchanged and the target price is decreased to $5.79 from $5.91.
Read MoreFBU – Credit Suisse rates the stock as Outperform
Credit Suisse resumes coverage with an Outperform rating and $7.20 target.
Read MoreSVW – UBS rates the stock as Buy
Buy rating retained with the target dropping to $27.35 from $27.50.
Read MoreMME – Morgans rates the stock as Add
The target price is increased to $2.04 from $1.97 and the Add rating is unchanged.
Read MoreBSL – Credit Suisse rates the stock as Outperform
Outperform retained. Target rises to $22.50 from $20.
Read MoreURW – Citi rates the stock as Sell
Sell maintained. Target rises to EUR27.70 from EUR21.20.
Read MoreAWC – Credit Suisse rates the stock as Outperform
Credit Suisse retains its Outperform rating with a target of $2.
Read More
